1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Disease Models, Animal

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, T; DeAngelis, RA; Hajishengallis, E; Hajishengallis, G; Hosur, KB; Lambris, JD; Maekawa, T; Ricklin, D	1
Acuna, SA; Atkins, H; Auer, RC; Bell, JC; Breitbach, CJ; Evgin, L; Falls, T; Findlay, CS; Goldstein, A; Hanwell, D; Ilkow, CS; Kirn, D; Lafrance, S; Lambris, JD; Lemay, CG; Lopez, R; Marguerie, M; McCart, JA; Parato, KA; Stahl, GL; Tanese de Souza, C; Thurman, JM	1
Abe, T; Hajishengallis, E; Hajishengallis, G; Lambris, JD; Maekawa, T	1

Reviews

1 review(s) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Disease Models, Animal

Article	Year
Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches. Advances in experimental medicine and biology, 2015, Volume: 865 Topics: Animals; Bacteroidaceae Infections; Complement Activation; Complement Inactivating Agents; Complement System Proteins; Disease Models, Animal; Dysbiosis; Host-Pathogen Interactions; Humans; Macaca fascicularis; Mice; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones; Receptors, Complement	2015

Article

Year

Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.

Advances in experimental medicine and biology, 2015, Volume: 865

Topics: Animals; Bacteroidaceae Infections; Complement Activation; Complement Inactivating Agents; Complement System Proteins; Disease Models, Animal; Dysbiosis; Host-Pathogen Interactions; Humans; Macaca fascicularis; Mice; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones; Receptors, Complement

2015

Other Studies

2 other study(ies) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Disease Models, Animal

Article	Year
Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis. Journal of immunology (Baltimore, Md. : 1950), 2014, Jun-15, Volume: 192, Issue:12 Topics: Animals; Bacteroidaceae Infections; Bone Resorption; Complement C3; Disease Models, Animal; Female; Humans; Inflammation Mediators; Macaca fascicularis; Male; Mice; Osteoclasts; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones	2014
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques. Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:6 Topics: Animals; Antibodies, Viral; Cell Line, Tumor; Chlorocebus aethiops; Disease Models, Animal; Drug Delivery Systems; Feasibility Studies; Female; HeLa Cells; Humans; Injections, Intralesional; Macaca fascicularis; Male; Neoplasms; Neutralization Tests; Oncolytic Virotherapy; Oncolytic Viruses; Pyridones; Rats; Rats, Inbred F344; Smallpox Vaccine; Vaccination; Vaccinia virus; Vero Cells	2015

Article

Year

Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Journal of immunology (Baltimore, Md. : 1950), 2014, Jun-15, Volume: 192, Issue:12

Topics: Animals; Bacteroidaceae Infections; Bone Resorption; Complement C3; Disease Models, Animal; Female; Humans; Inflammation Mediators; Macaca fascicularis; Male; Mice; Osteoclasts; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones

2014

Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques.

Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:6

Topics: Animals; Antibodies, Viral; Cell Line, Tumor; Chlorocebus aethiops; Disease Models, Animal; Drug Delivery Systems; Feasibility Studies; Female; HeLa Cells; Humans; Injections, Intralesional; Macaca fascicularis; Male; Neoplasms; Neutralization Tests; Oncolytic Virotherapy; Oncolytic Viruses; Pyridones; Rats; Rats, Inbred F344; Smallpox Vaccine; Vaccination; Vaccinia virus; Vero Cells

2015